Merkel cell polyomavirus: Molecular insights into the most recently discovered human tumour virus

Cancers

Volumn 6, Issue 3, 2014, Pages 1267-1297

  Stakaityte, Gabriele ^a   Wood, Jennifer J ^a   Knight, Laura M ^a   Abdul Sada, Hussein ^a   Adzahar, Noor Suhana ^a   Nwogu, Nnenna ^a   Macdonald, Andrew ^a   Whitehouse, Adrian ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Large T antigen; Merkel cell carcinoma; Merkel cell polyomavirus; Small T antigen; Tumourigenesis

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; ETOPOSIDE; INTERFERON; MICRORNA; ONCOPROTEIN; PATTERN RECOGNITION RECEPTOR; PAZOPANIB; PLATINUM DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN; VIRUS SMALL T ANTIGEN;

CANCER RADIOTHERAPY; COMMENSAL; GENE LOCUS; HUMAN; INNATE IMMUNITY; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; MOLECULAR BIOLOGY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); REVIEW; SIMIAN VIRUS 40; SKIN CARCINOGENESIS; TUMOR VIRUS; VIROLOGY; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS GENOME; VIRUS LOAD; VIRUS REACTIVATION; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84903539246     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers6031267     Document Type: Review

References (152)

1. Parkin, D. M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 2006, 118, 3030-3044.
2. Javier, R. T.; Butel, J. S. The History of tumor virology. Cancer Res. 2008, 68, 7693-7706.
3. Moore, P. S.; Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 2010, 10, 878-889.
4. Stewart, S. E.; Eddy, B. E.; Borgese, N. Neoplasms in mice inoculated with a tumor agent carried in tissue culture. J. Natl. Cancer Inst. 1958, 20, 1223-1243.
5. Sweet, B. H.; Hilleman, M. R. The Vacuolating Virus, SV40. Exp. Biol. Med. 1960, 105, 420-427.
6. Feng, H.; Shuda, M.; Chang, Y.; Moore, P. S. Clonal integration of a polyomavirus in human merkel cell carcinoma. Science 2008, 319, 1096-1100.
7. Kaae, J.; Hansen, A. V.; Biggar, R. J.; Boyd, H. A.; Moore, P. S.; Wohlfahrt, J.; Melbye, M. Merkel cell carcinoma: Incidence, mortality, and risk of other cancers. J. Natl. Cancer Inst. 2010, 102, 793-801.
8. Lanoy, E.; Costagliola, D.; Engels, E. A. Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int. J. Cancer 2010, 126, 1724-1731.
9. Toker, C. Trabecular Carcinoma of the Skin. Arch. Dermatol. 1972, 105, 107-110.
10. Merkel, F. Tastzellen and Tastkoerperchenbei den Hausthieren und beim Menschen. Arch. Mikr. Anat. 1875, 11, 636-652.
11. Lacour, J. P.; Dubois, D.; Pisani, A.; Ortonne, J. P. Anatomical mapping of Merkel cells in normal human adult epidermis. Br. J. Dermatol. 1991, 125, 535-542.
12. May, C. A.; Osterland, I. Merkel cell distribution in the human eyelid. Eur. J. Histochem. 2013, 57, 224-226.
13. Koljonen, V.; Kluger, N.; Sihto, H.; Bohling, T. Lateral distribution of merkel cell carcinoma in a nationwide cohort. J. Eur. Acad. Dermatol. Venereol. 2013, 27, 884-888.
14. Hodgson, N. C. Merkel Cell Carcinoma: Changing Incidence Trends. J. Surg. Oncol. 2005, 89, 1-4.
15. Bzhalava, D.; Bray, F.; Storm, H.; Dillner, J. Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia. Br. J. Cancer 2011, 104, 178-180.
16. Gupta, S. G.; Wang, L. C.; Penas, P. F.; Gellenthin, M.; Lee, S. J.; Nghiem, P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The dana-farber experience and meta-analysis of the literature. Arch. Dermatol. 2006, 142, 685-690.
17. Vernadakis, S.; Moris, D.; Bankfalvi, A.; Makris, N.; Sotiropoulos, G. C. Metastatic Merkel cell carcinoma (MCC) of pancreas and breast: A unique case. World J. Surg. Oncol. 2013, 11, 261.
18. Suttie, C. F.; Hruby, G.; Horvath, L.; Thompson, J. Cardiac metastasis in Merkel cell carcinoma. J. Clin. Oncol. 2014, 32, 1-2.
19. Vasileiadis, I.; Sofopoulos, M.; Arnogiannaki, N.; Georgopoulos, S. A Merkel cell carcinoma metastatic to the tonsil: A case report and review of the literature. J. Oral Maxillofac. Surg. 2013, 71, 1812.
20. Laude, H. C.; Jonchère, B.; Maubec, E.; Carlotti, A.; Marinho, E.; Couturaud, B.; Peter, M.; Sastre-Garau, X.; Avril, M.-F.; Dupin, N.; et al. Distinct Merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog. 2010, 6, e1001076.
21. Martel-Jantin, C.; Filippone, C.; Cassar, O.; Peter, M.; Tomasic, G.; Vielh, P.; Briere, J.; Petrella, T.; Aubriot-Lorton, M. H.; Mortier, L.; et al. Genetic Variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology 2012, 426, 134-142.
22. Sastre-Garau, X.; Peter, M.; Avril, M.-F.; Laude, H.; Couturier, J.; Rozenberg, F.; Almeida, A.; Boitier, F.; Carlotti, A.; Couturaud, B.; et al. Merkel cell carcinoma of the skin: Pathological and molecular evidence for a causative role of MCV in oncogenesis. J. Pathol. 2009, 218, 48-56.
23. Rodig, S. J.; Cheng, J.; Wardzala, J.; DoRosario, A.; Scanlon, J. J.; Laga, A. C.; Martinez-Fernandez, A.; Barletta, J. A.; Bellizzi, A. M.; Sadasivam, S.; et al. Improved detection suggests all Merkel cell carcinomas harbor merkel polyomavirus. J. Clin. Invest. 2012, 122, 4645-4653.
24. Donepudi, S.; DeConti, R. C.; Samlowski, W. E. Recent Advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma. Semin. Oncol. 2012, 39, 163-172.
25. Shuda, M.; Arora, R.; Kwun, H. J.; Feng, H.; Sarid, R.; Fernandez-Figueras, M.-T.; Tolstov, Y.; Gjoerup, O.; Mansukhani, M. M.; Swerdlow, S. H.; et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int. J. Cancer 2009, 125, 1243-1249.
26. Viscidi, R. P.; Rollison, D. E.; Sondak, V. K.; Silver, B.; Messina, J. L.; Giuliano, A. R.; Fulp, W.; Ajidahun, A.; Rivanera, D. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin. Vaccine Immunol. 2011, 18, 1737-1743.
27. Tolstov, Y. L.; Pastrana, D. V.; Feng, H.; Becker, J. C.; Jenkins, J. J.; Moschos, S.; Chang, Y.; Buck, C. B.; Moore, P. S. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int. J. Cancer 2009, 125, 1250-1256.
28. Becker, J. C.; Houben, R.; Ugurel, S.; Trefzer, U.; Pfohler, C.; Schrama, D. MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J. Invest. Dermatol. 2009, 129, 248-250.
29. Matsushita, M.; Kuwamoto, S.; Iwasaki, T.; Higaki-Mori, H.; Yashima, S.; Kato, M.; Murakami, I.; Horie, Y.; Kitamura, Y.; Hayashi, K. Detection of Merkel cell polyomavirus in the human tissues from 41 japanese autopsy cases using polymerase chain reaction. Intervirology 2013, 56, 1-5.
30. Martel-Jantin, C.; Pedergnana, V.; Nicol, J. T. J.; Leblond, V.; Trégouët, D.-A.; Tortevoye, P.; Plancoulaine, S.; Coursaget, P.; Touzé, A.; Abel, L.; et al. Merkel Cell polyomavirus infection occurs during early childhood and is transmitted between siblings. J. Clin. Virol. 2013, 58, 288-291.
31. van der Meijden, E.; Bialasiewicz, S.; Rockett, R. J.; Tozer, S. J.; Sloots, T. P.; Feltkamp, M. C. W. Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin. PLoS One 2013, 8, e81078: 1-e81078: 9.
32. Hashida, Y.; Imajoh, M.; Kamioka, M.; Taniguchi, A.; Kuroda, N.; Hayashi, K.; Nakajima, H.; Sano, S.; Daibata, M. Phylogenetic analysis of Merkel cell polyomavirus based on full-length LT and VP1 gene sequences derived from neoplastic tumours in Japanese patients. J. Gen. Virol. 2014, 95, 135-141.
33. Matsushita, M.; Iwasaki, T.; Kuwamoto, S.; Kato, M.; Nagata, K.; Murakami, I.; Kitamura, Y.; Hayashi, K. Merkel cell polyomavirus (MCPyV) strains in Japanese Merkel cell carcinomas (MCC) are distinct from caucasian type MCPyVs: Genetic variability and phylogeny of MCPyV genomes obtained from Japanese MCPyV-infected MCCs. Virus Genes 2014, 48, 233-242.
34. Martel-Jantin, C.; Filippone, C.; Tortevoye, P.; Afonso, P. V.; Betsem, E.; Descorps-Declere, S.; Nicol, J. T. J.; Touzé, A.; Coursaget, P.; Crouzat, M.; et al. Molecular epidemiology of Merkel cell polyomavirus: Evidence for geographically related variant genotypes. J. Clin. Microbiol. 2014, 52, 1687-1690.
35. Dalianis, T.; Ramqvist, T.; Andreasson, K.; Kean, J. M.; Garcea, R. L. KI, WU and Merkel cell polyomaviruses: A new era for human polyomavirus research. Semin. Cancer Biol. 2009, 19, 270-275.
36. Johne, R.; Buck, C. B.; Allander, T.; Atwood, W. J.; Garcea, R. L.; Imperiale, M. J.; Major, E. O.; Ramqvist, T.; Norkin, L. C. Taxonomical developments in the family polyomaviridae. Arch. Virol. 2011, 156, 1627-1634.
37. Kwun, H. J.; Guastafierro, A.; Shuda, M.; Meinke, G.; Bohm, A.; Moore, P. S.; Chang, Y. The minimum replication origin of Merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication. J. Virol. 2009, 83, 12118-12128.
38. Peden, K. W. C.; Srinivasan, A.; Farber, J. M.; Pipas, J. M. Mutants with changes within or near a hydrophobic region of simian virus-40 Large Tumor Antigen are Defective for Binding Cellular Protein p53. Virology 1989, 168, 13-21.
39. Kierstead, T. D.; Tevethia, M. J. Association of p53 binding and immortalization of primary C57bl/6 mouse embryo fibroblasts by using simian-virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 1993, 67, 1817-1829.
40. Topalis, D.; Andrei, G.; Snoeck, R. The large tumor antigen: A "Swiss Army Knife" protein possessing the functions required for the polyomavirus life cycle. Antiviral Res. 2013, 97, 122-136.
41. Nakamura, T.; Sato, Y.; Watanabe, D.; Ito, H.; Shimonohara, N.; Tsuji, T.; Nakajima, N.; Suzuki, Y.; Matsuo, K.; Nakagawa, H.; et al. Nuclear localization of Merkel cell polyomavirus large T antigen in Merkel cell carcinoma. Virology 2010, 398, 273-279.
42. Liu, X.; Hein, J.; Richardson, S. C. W.; Basse, P. H.; Toptan, T.; Moore, P. S.; Gjoerup, O. V.; Chang, Y. Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human vam6p from the cytoplasm to the nucleus. J. Biol. Chem. 2011, 286, 17079-17090.
43. DeCaprio, J. A.; Ludlow, J. W.; Figge, J.; Shew, J. Y.; Huang, C. M.; Lee, W. H.; Marsilio, E.; Paucha, E.; Livingston, D. M. SV40 large tumor-antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988, 54, 275-283.
44. Srinivasan, A.; McClellan, A. J.; Vartikar, J.; Marks, I.; Cantalupo, P.; Li, Y.; Whyte, P.; Rundell, K.; Brodsky, J. L.; Pipas, J. M. The amino-terminal transforming region of simian virus 40 large T and small T antigens functions as a J domain. Mol. Cell. Biol. 1997, 17, 4761-4773.
45. Ali, S. H.; Kasper, J. S.; Arai, T.; DeCaprio, J. A. Cu17/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation. J. Virol. 2004, 78, 2749-2757.
46. Cotsiki, M.; Lock, R. L.; Cheng, Y.; Williams, G. L.; Zhao, J.; Perera, D.; Freire, R.; Entwistle, A.; Golemis, E. A.; Roberts, T. M.; et al. Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc. Natl. Acad. Sci. USA 2004, 101, 947-952.
47. Lane, D. P.; Crawford, L. V. T-antigen is bound to a host protein in SV40-transformed cells. Nature 1979, 278, 261-263.
48. Poulin, D. L.; Kung, A. L.; DeCaprio, J. A. p53 Targets Simian virus 40 large T antigen for acetylation by CBP. J. Virol. 2004, 78, 8245-8253.
49. Seo, G. J.; Chen, C. J.; Sullivan, C. S. Merkel cell polyomavirus encodes a MicroRNA with the ability to autoregulate viral gene expression. Virology 2009, 383, 183-187.
50. Zerrahn, J.; Knippschild, U.; Winkler, T.; Deppert, W. Independent expression of the transforming amino-terminal domain of SV40 large T-antigen from an alternatively spliced 3rd SV40 early messenger-RNA. EMBO J. 1993, 12, 4739-4746.
51. Comerford, S. A.; Schultz, N.; Hinnant, E. A.; Klapproth, S.; Hammer, R. E. Comparative analysis of SV40 17kT and LT function in vivo demonstrates that it's C-terminus reprograms hepatic gene expression and is necessary for tumorigenesis in the liver. Oncogenesis 2012, 1, e28.
52. Moens, U.; van Ghelue, M.; Johannessen, M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell. Mol. Life. Sci. 2007, 64, 1656-1678.
53. Pallas, D. C.; Shahrik, L. K.; Martin, B. L.; Jaspers, S.; Miller, T. B.; Brautigan, D. L.; Roberts, T. M. Polyoma small and middle T-antigens and SV40 small T-antigen form stable complexes with protein phosphatase-2A. Cell 1990, 60, 167-176.
54. Griffiths, D. A.; Abdul-Sada, H.; Knight, L. M.; Jackson, B. R.; Richards, K.; Prescott, E. L.; Peach, A. H.; Blair, G. E.; Macdonald, A.; Whitehouse, A. Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling. J. Virol. 2013, 87, 13853-13867.
55. Kwun, H. J.; Shuda, M.; Feng, H.; Camacho, C. J.; Moore, P. S.; Chang, Y. Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by Targeting the cellular ubiquitin ligase SCFFbw7. Cell Host Microbe 2013, 14, 125-135.
56. Carter, J. J.; Daugherty, M. D.; Qi, X.; Bheda-Malge, A.; Wipf, G. C.; Robinson, K.; Roman, A.; Malik, H. S.; Galloway, D. A. Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes. Proc. Natl. Acad. Sci. USA 2013, 110, 12744-12749.
57. Schowalter, R. M.; Buck, C. B. The Merkel cell polyomavirus minor capsid protein. PLoS Pathog. 2013, 9, e1003558.
58. Neu, U.; Hengel, H.; Blaum, B. S.; Schowalter, R. M.; Macejak, D.; Gilbert, M.; Wakarchuk, W. W.; Imamura, A.; Ando, H.; Kiso, M.; et al. Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog. 2012, 8, e1002738.
59. Sullivan, C. S.; Grundhoff, A. T.; Tevethia, S.; Pipas, J. M.; Ganem, D. SV40-encoded MicroRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005, 435, 682-686.
60. Seo, G. J.; Fink, L. H. L.; O'Hara, B.; Atwood, W. J.; Sullivan, C. S. Evolutionarily conserved function of a viral microRNA. J. Virol. 2008, 82, 9823-9828.
61. Lee, S.; Paulson, K. G.; Murchison, E. P.; Afanasiev, O. K.; Alkan, C.; Leonard, J. H.; Byrd, D. R.; Hannon, G. J.; Nghiem, P. Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas. J. Clin. Virol. 2011, 52, 272-275.
62. Schowalter, R. M.; Pastrana, D. V.; Pumphrey, K. A.; Moyer, A. L.; Buck, C. B. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010, 7, 509-515.
63. Schowalter, R. M.; Reinhold, W. C.; Buck, C. B. Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS One 2012, 7, e42181.
64. Schowalter, R. M.; Pastrana, D. V.; Buck, C. B. Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog. 2011, 7, e1002161.
65. Bauer, P. H.; Cui, C.; Stehle, T.; Harrison, S. C.; DeCaprio, J. A.; Benjamin, T. L. Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse. J. Virol. 1999, 7, 5826-5832.
66. Sapp, M.; Day, P. M. Structure, attachment and entry of polyoma-and papillomaviruses. Virology 2009, 384, 400-409.
67. Wessel, R.; Schweizer, J.; Stahl, H. Simian virus-40 T-antigen DNA helicase is a hexamer which forms a binary complex during bidirectional unwinding from the viral origin of DNA-replication. J. Virol. 1992, 66, 804-815.
68. Harrison, C. J.; Meinke, G.; Kwun, H. J.; Rogalin, H.; Phelan, P. J.; Bullock, P. A.; Chang, Y.; Moore, P. S.; Bohm, A. Asymmetric assembly of Merkel cell polyomavirus large T-antigen origin binding domains at the viral origin. J. Molec. Biol. 2011, 409, 529-542.
69. Feng, H.; Kwun, H. J.; Liu, X.; Gjoerup, O.; Stolz, D. B.; Chang, Y.; Moore, P. S. Cellular and viral factors regulating Merkel cell polyomavirus replication. PLoS One 2011, 6, e22468.
70. Wang, X.; Li, J.; Schowalter, R. M.; Jiao, J.; Buck, C. B.; You, J. Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication. PLoS Pathog. 2012, 8, e1003021.
71. Tsang, S. H.; Wang, X.; Li, J.; Buck, C. B.; You, J. Host DNA damage response factors localize to Merkel cell polyomavirus DNA replication sites to support efficient viral DNA replication. J. Virol. 2014, 88, 3285-3297.
72. Gillespie, K. A.; Mehta, K. P.; Laimins, L. A.; Moody, C. A. Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J. Virol. 2012, 86, 9520-9526.
73. Wang, X.; Helfer, C. M.; Pancholi, N.; Bradner, J. E.; You, J. Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J. Virol. 2013, 87, 3871-3884.
74. Shuda, M.; Kwun, H. J.; Feng, H.; Chang, Y.; Moore, P. S. Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J. Clin. Invest. 2011, 121, 3623-3634.
75. Welcker, M.; Clurman, B. E. FBW7 ubiquitin ligase: A tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 2008, 8, 83-93.
76. Maser, R. S.; Choudhury, B.; Campbell, P. J.; Feng, B.; Wong, K. K.; Protopopov, A.; O'Neil, J.; Gutierrez, A.; Ivanova, E.; Perna, I.; et al. Chromosomally Unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007, 447, 966-971.
77. Wood, L. D.; Parsons, D. W.; Jones, S.; Lin, J.; Sjöblom, T.; Leary, R. J.; Shen, D.; Boca, S. M.; Barber, T.; Ptak, J.; et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318, 1108-1113.
78. Mao, J. H.; Perez-Losada, J.; Wu, D.; Delrosario, R.; Tsunematsu, R.; Nakayama, K. I.; Brown, K.; Bryson, S.; Balmain, A. Fbxw7/Cdc4 Is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 2004, 432, 775-779.
79. Rajagopalan, H.; Jallepalli, P. V.; Rago, C.; Velculescu, V. E.; Kinzler, K. W.; Vogelstein, B.; Lengauer, C. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004, 428, 77-81.
80. Hayden, M. S.; Ghosh, S. Signaling to NF-kappa B. Genes Dev. 2004, 18, 2195-2224.
81. Le Negrate, G. Viral interference with innate immunity by preventing NF-kappa B activity. Cell. Microbiol. 2012, 14, 168-181.
82. Joo, M. S.; Hahn, Y. S.; Kwon, M.; Sadikot, R. T.; Blackwell, T. S.; Christman, J. W. Hepatitis C virus core protein suppresses NF-kappa B activation and cyclooxygenase-2 expression by direct interaction with I kappa B kinase beta. J. Virol. 2005, 79, 7648-7657.
83. Spitkovsky, D.; Hehner, S. P.; Hofmann, T. G.; Moller, A.; Schmitz, M. L. The Human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the I kappa B kinase complex. J. Biol. Chem. 2002, 277, 25576-25582.
84. Randall, C. M. H.; Jokela, J. A.; Shisler, J. L. The MC159 Protein from the molluscum contagiosum poxvirus inhibits NF-kappa B activation by interacting with the I kappa B kinase complex. J. Immunol. 2012, 188, 2371-2379.
85. Fliss, P. M.; Jowers, T. P.; Brinkmann, M. M.; Holstermann, B.; Mack, C.; Dickinson, P.; Hohenberg, H.; Ghazal, P.; Brune, W. Viral mediated redirection of NEMO/IKK gamma to autophagosomes curtails the inflammatory cascade. PLoS Pathog. 2012, 8, e1002517.
86. Moreno, C. S.; Ramachandran, S.; Ashby, D. G.; Laycock, N.; Plattner, C. A.; Chen, W.; Hahn, W. C.; Pallas, D. C. Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56 gamma knockdown. Cancer Res. 2004, 64, 6978-6988.
87. Shahzad, N.; Shuda, M.; Gheit, T.; Kwun, H. J.; Cornet, I.; Saidj, D.; Zannetti, C.; Hasan, U.; Chang, Y.; Moore, P. S.; et al. The T antigen locus of Merkel Cell polyomavirus downregulates human toll-like receptor 9 expression. J. Virol. 2013, 87, 13009-13019.
88. Takeda, K.; Akira, S. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17, 1-14.
89. Beutler, B. Inferences, questions and possibilities in toll-like receptor signalling. Nature 2004, 430, 257-263.
90. Tsujimura, H.; Tamura, T.; Kong, H. J.; Nishiyama, A.; Ishii, K. J.; Klinman, D. M.; Ozato, K. Toll-like receptor 9 signaling activates NF-κB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 2004, 172, 6820-6827.
91. Fathallah, I.; Parroche, P.; Gruffat, H.; Zannetti, C.; Johansson, H.; Yue, J.; Manet, E.; Tommasino, M.; Sylla, B. S.; Hasan, U. A. EBV latent membrane protein 1 is a negative regulator of TLR9. J. Immunol. 2010, 185, 6439-6447.
92. Hasan, U. A.; Bates, E.; Takeshita, F.; Biliato, A.; Accardi, R.; Bouvard, V.; Mansour, M.; Vincent, I.; Gissmann, L.; Iftner, T.; et al. TLR9 Expression and Function is abolished by the cervical cancer-associated human papillomavirus type 16. J. Immunol. 2007, 178, 3186-3197.
93. Vincent, I. E.; Zannetti, C.; Lucifora, J.; Norder, H.; Protzer, U.; Hainaut, P.; Zoulim, F.; Tommasino, M.; Trépo, C.; Hasan, U.; et al. Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PLoS One 2011, 6, e26315.
94. Neumann, F.; Borchert, S.; Schmidt, C.; Reimer, R.; Hohenberg, H.; Fischer, N.; Grundhoff, A. Replication, gene expression and particle production by a consensus Merkel cell polyomavirus (MCPyV) genome. PLoS One 2011, 6, e29112.
95. Khalili, K.; White, M. K.; Sawa, H.; Nagashima, K.; Safak, M. The agnoprotein of polyomaviruses: A multifunctional auxiliary protein. J. Cell Physiol. 2005, 204, 1-7.
96. Daniels, R.; Sadowicz, D.; Hebert, D. N. A Very late viral protein triggers the lytic release of SV40. PLoS Pathog. 2007, 3, 0929-0938.
97. Clayson, E. T.; Brando, L. V.; Compans, R. W. Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. J. Virol. 1989, 63, 2278-2288.
98. Hahn, W. C.; Dessain, S. K.; Brooks, M. W.; King, J. E.; Elenbaas, B.; Sabatini, D. M.; DeCaprio, J. A.; Weinberg, R. A. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 2002, 22, 2111-2123.
99. Bikel, I.; Montano, X.; Agha, M. E.; Brown, M.; McCormack, M.; Boltax, J.; Livingston, D. M. SV40 small T-antigen enhances the transformation activity of limiting concentrations of SV40 Large T-antigen. Cell 1987, 48, 321-330.
100. Houben, R.; Shuda, M.; Weinkam, R.; Schrama, D.; Feng, H.; Chang, Y.; Moore, P. S.; Becker, J. C. Merkel cell polyomavirus-infected merkel cell carcinoma cells require expression of viral T antigens. J. Virol. 2010, 84, 7064-7072.
101. Fischer, N.; Brandner, J.; Fuchs, F.; Moll, I.; Grundhoff, A. Detection of merkel cell polyomavirus (MCPyV) in Merkel cell carcinoma cell lines: Cell morphology and growth phenotype do not reflect presence of the virus. Int. J. Cancer 2010, 126, 2133-2142.
102. Katano, H.; Ito, H.; Suzuki, Y.; Nakamura, T.; Sato, Y.; Tsuji, T.; Matsuo, K.; Nakagawa, H.; Sata, T. Detection of Merkel cell polyomavirus in Merkel cell carcinoma and Kaposi's sarcoma. J. Med. Virol. 2009, 81, 1951-1958.
103. Shuda, M.; Feng, H.; Kwun, H. J.; Rosen, S. T.; Gjoerup, O.; Moore, P. S.; Chang, Y. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. USA 2008, 105, 16272-16277.
104. Kassem, A.; Schopflin, A.; Diaz, C.; Weyers, W.; Stickeler, E.; Werner, M.; Zur Hausen, A. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 2008, 68, 5009-5013.
105. DeCaprio, J. A.; Garcea, R. L. A cornucopia of human polyomaviruses. Nat. Rev. Microbiol. 2013, 11, 264-276.
106. Demetriou, S. K.; Ona-Vu, K.; Sullivan, E. M.; Dong, T. K.; Hsu, S.-W.; Oh, D. H. Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen. Int. J. Cancer 2012, 131, 1818-1827.
107. Busam, K. J.; Jungbluth, A. A.; Rekthman, N.; Coit, D.; Pulitzer, M.; Bini, J.; Arora, R.; Hanson, N. C.; Tassello, J. A.; Frosina, D.; et al. Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am. J. Surg. Pathol. 2009, 33, 1378-1385.
108. Shuda, M.; Arora, R.; Kwun, H. J.; Feng, H.; Sarid, R.; Fernandez-Figueras, M.-T.; Tolstov, Y.; Gjoerup, O.; Mansukhani, M. M.; Swerdlow, S. H.; et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int. J. Cancer 2009, 125, 1243-1249.
109. Brown, M.; McCormack, M.; Zinn, K. G.; Farrell, M. P.; Bikel, I.; Livingston, D. M. A recombinant murine retrovirus for simian virus-40 large T-cDNA transforms mouse fibroblasts to anchorage-independent growth. J. Virol. 1986, 60, 290-293.
110. Vousden, K. H.; Lane, D. P. p53 in health and disease. Nat. Rev. Mol. Cell. Biol. 2007, 8, 275-283.
111. Sullivan, C. S.; Cantalupo, P.; Pipas, J. M. The molecular chaperone activity of simian virus 40 large T antigen is required to Disrupt Rb-E2F family complexes by an ATP-dependent mechanism. Mol. Cell. Biol. 2000, 20, 6233-6243.
112. Cheng, J.; Rozenblatt-Rosen, O.; Paulson, K. G.; Nghiem, P.; DeCaprio, J. A. Merkel cell polyomavirus large T antigen has growth-promoting and inhibitory activities. J. Virol. 2013, 87, 6118-6126.
113. Li, J.; Wang, X.; Diaz, J.; Tsang, S. H.; Buck, C. B.; You, J. Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation. J. Virol. 2013, 87, 9173-9188.
114. Shi, Y. L.; Dodson, G. E., Rundell, K.; Tibbetts, R. S. Ataxia-telangiectasia-mutated (ATM) Is a T-antigen kinase that controls SV40 viral replication in vivo. J. Biol. Chem. 2005, 280, 40195-40200.
115. Arora, R.; Shuda, M.; Guastafierro, A.; Feng, H.; Toptan, T., Tolstov, Y.; Normolle, D.; Vollmer, L. L.; Vogt, A.; Doemling, A.; et al. Survivin is a therapeutic target in Merkel cell carcinoma. Sci. Transl. Med. 2012, 4, 133ra56.
116. Coumar, M. S.; Tsai, F. Y.; Kanwar, J. R.; Sarvagalla, S.; Cheung, C. H. A. Treat cancers by targeting survivin: Just a dream or future reality? Cancer Treat. Rev. 2013, 39, 802-811.
117. Angermeyer, S.; Hesbacher, S.; Becker, J. C.; Schrama, D.; Houben, R. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen. J. Invest. Dermatol. 2013, 133, 2059-2064.
118. Sontag, E.; Fedorov, S.; Kamibayashi, C.; Robbins, D.; Cobb, M.; Mumby, M. The interaction of SV40 small tumor-antigen with protein phosphatase-2a stimulates the MAP kinase pathway and induces cell-proliferation. Cell 1993, 75, 887-897.
119. Ruediger, R.; Hentz, M.; Fait, J.; Mumby, M.; Walter, G. Molecular Model of the a subunit of protein phosphatase 2A: Interaction with other subunits and tumor antigens. J. Virol. 1994, 68, 123-129.
120. Yang, S. I.; Lickteig, R. L.; Estes, R.; Rundell, K.; Walter, G.; Mumby, M. C. Control of protein phosphatase-2A by simian virus-40 small-T antigen. Mol. Cell. Biol. 1991, 11, 1988-1995.
121. Yu, J.; Boyapati, A.; Rundell, K. Critical role for SV40 small-T antigen in human cell transformation. Virology 2001, 290, 192-198.
122. Zhao, J. J.; Gjoerup, O. V.; Subramanian, R. R.; Cheng, Y.; Chen, W.; Roberts, T. M.; Hahn, W. C. Human Mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 2003, 3, 483-495.
123. Rodriguez-Viciana, P.; Collins, C.; Fried, M. Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. Proc. Natl. Acad. Sci. USA 2006, 103, 19290-19295.
124. Buchkovich, N. J.; Yu, Y.; Zampieri, C. A.; Alwine, J. C. The TORrid affairs of viruses: Effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nat. Rev. Microbiol. 2008, 6, 266-275.
125. Dowling, R. J. O.; Topisirovic, I.; Alain, T.; Bidinosti, M.; Fonseca, B. D.; Petroulakis, E.; Wang, X.; Larsson, O.; Selvaraj, A.; Liu, Y.; et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 2010, 328, 1172-1176.
126. She, Q.-B.; Halilovic, E.; Ye, Q.; Zhen, W.; Shirasawa, S.; Sasazuki, T.; Solit, D. B.; Rosen, N. 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell 2010, 18, 39-51.
127. Richter, J. D.; Sonenberg, N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005, 433, 477-480.
128. Pause, A.; Belsham, G. J.; Gingras, A. C.; Donzé, O.; Lin, T. A.; Lawrence, J. C., Jr.; Sonenberg, N. Insulin-dependent stimulation of protein-synthesis by phosphorylation of a regulator of 5'-Cap function. Nature 1994, 371, 762-767.
129. Lazariskaratzas, A.; Montine, K. S.; Sonenberg, N. Malignant transformation by a eukaryotic initiation-factor subunit that binds to messenger-RNA 5' cap. Nature 1990, 345, 544-547.
130. Avdulov, S.; Li, S.; Michalek, V.; Burrichter, D.; Peterson, M.; Perlman, D. M.; Manivel, J. C.; Sonenberg, N.; Yee, D.; Bitterman, P. B.; et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 2004, 5, 553-563.
131. Beretta, L.; Gingras, A. C.; Svitkin, Y. V.; Hall, M. N.; Sonenberg, N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 1996, 15, 658-664.
132. Yu, J.; Boyapati, A.; Rundell, K. Critical role for SV40 small-T antigen in human cell transformation. Virology 2001, 290, 192-198.
133. Jouary, T.; Leyral, C.; Dreno, B.; Doussau, A.; Sassolas, B.; Beylot-Barry, M.; Renaud-Vilmer, C.; Guillot, B.; Bernard, P.; Lok, C.; et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: A multicentric prospective randomized study. Ann. Oncol. 2012, 23 1074-1080.
134. Pape, E.; Rezvoy, N.; Penel, N.; Salleron, J.; Martinot, V.; Guerreschi, P.; Dziwniel, V.; Darras, S.; Mirabel, X.; Mortier, L. Radiotherapy alone for Merkel cell carcinoma: A comparative and retrospective study of 25 patients. J. Am. Acad. Dermatol. 2011, 65, 983-990.
135. Tai, P. T.; Yu, E.; Winquist, E.; Hammond, A.; Stitt, L.; Tonita, J.; Gilchrist, J. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: Case series and review of 204 cases. J. Clin. Oncol. 2000, 18, 2493-2499.
136. Willmes, C.; Adam, C.; Alb, M.; Völkert, L.; Houben, R.; Becker, J. C.; Schrama, D. Type I and II IFNs inhibit Merkel cell carcinoma via modulation of the Merkel Cell polyomavirus T antigens. Cancer Res. 2012, 72, 2120-2128.
137. Biver-Dalle, C.; Nguyen, T.; Touzé, A.; Saccomani, C.; Penz, S.; Cunat-Peultier, S.; Riou-Gotta, M.-O.; Humbert, P.; Coursaget, P.; Aubin, F. Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus. Acta Oncol. 2010, 50, 479-480.
138. Dresang, L. R.; Guastafierro, A.; Arora, R.; Normolle, D.; Chang, Y.; Moore, P. S. Response of Merkel cell polyomavirus-positive Merkel cell carcinoma xenografts to a survivin inhibitor. PLoS One 2013, 11, e80543.
139. Davids, M.; Charlton, A.; Ng, S. S.; Chong, M. L.; Laubscher, K.; Dar, M.; Hodge, J.; Soong, R.; Goh, B. C. Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. J. Clin. Oncol. 2009, 27, e97-e100.
140. Sugamata, A.; Goya, K.; Yoshizawa, N. A Case of complete spontaneous regression of extremely advanced Merkel cell carcinoma. J. Surg. Case Rep. 2011, 10, 7.
141. Iyer, J. G.; Afanasiev, O. K.; McClurkan, C.; Paulson, K.; Nagase, K.; Jing, L.; Marshak, J. O.; Dong, L.; Carter, J.; Lai, I.; et al. Merkel cell polyomavirus-specific CD8+ and CD4+ T-cell responses identified in Merkel cell carcinomas and blood. Clin. Cancer Res. 2011, 17, 6671-6680.
142. Lyngaa, R.; Pedersen, N. W.; Schrama, D.; Thrue, C. A.; Ibrani, D.; Met, Ö.; Thor Straten, P.; Nghiem, P.; Becker, J. C.; Hadrup, S. R. T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from healthy donors. Clin. Cancer Res. 2014, 20, 1768-1778.
143. Gomez, B.; He, L.; Tsai, Y. C.; Wu, T.-C.; Viscidi, R. P.; Hung, C.-F. Creation of a Merkel cell polyomavirus small T antigen-expressing murine tumor model and a DNA vaccine targeting small T antigen. Cell Biosci. 2013, 3, 29.
144. Zeng, Q.; Gomez, B. P.; Viscidi, R. P.; Peng, S.; He, L.; Ma, B.; Wu, T.-C.; Hung, C.-F. Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine 2012, 30, 1322-1329.
145. Afanasiev, O. K.; Yelistratova, L.; Miller, N.; Nagase, K.; Paulson, K.; Iyer, J. G.; Ibrani, D.; Koelle, D. M.; Nghiem, P. Merkel polyomavirus-specific T cells fluctuate with Merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers. Clin. Cancer Res. 2013, 19, 5351-5360.
146. Pantulu, N. D.; Pallasch, C. P.; Kurz, A. K.; Kassem, A.; Frenzel, L.; Sodenkamp, S.; Kvasnicka, H. M.; Wendtner, C. M.; Zur Hausen, A. Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells. Blood 2010, 116, 5280-5284.
147. Koljonen, V.; Kukko, H.; Pukkala, E.; Sankila, R.; Bohling, T.; Tukiainen, E.; Sihto, H.; Joensuu, H. Chronic lymphocytic leukaemia patients have a high risk of Merkel-Cell polyomavirus DNA-positive Merkel cell carcinoma. Br. J. Cancer 2009, 101, 1444-1447.
148. Teman, C. J.; Tripp, S. R.; Perkins, S. L.; Duncavage, E. J. Merkel cell polyomavirus (MCPyV) in chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Res. 2011, 35, 689-692.
149. Andres, C.; Belloni, B.; Puchta, U.; Sander, C. A.; Flaig, M. J. Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumors. J. Cutan. Pathol. 2010, 37, 28-34.
150. Reisinger, D. M.; Shiffer, J. D.; Cognetta, A. B., Jr.; Chang, Y.; Moore, P. S. Lack of evidence for basal or squamous cell carcinoma infection with Merkel cell polyomavirus in immunocompetent patients with Merkel cell carcinoma. J. Am. Acad. Dermatol. 2010, 63, 400-403.
151. Rollison, D. E.; Giuliano, A. R.; Messina, J. L.; Fenske, N. A.; Cherpelis, B. S.; Sondak, V. K.; Roetzheim, R. G.; Iannacone, M. R.; Michael, K. M.; Gheit, T.; et al. Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2012, 21, 74-81.
152. Dworkin, A. M.; Tseng, S. Y.; Allain, D. C.; Iwenofu, O. H.; Peters, S. B.; Toland, A. E. Merkel cell polyomavirus in cutaneous squamous cell carcinoma of immunocompetent individuals. J. Invest. Dermatol. 2009, 129, 2868-2874.